Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
43,212,667
-
Total 13F shares
-
49,004,390
-
Share change
-
+1,806,950
-
Total reported value
-
$2,019,479,072
-
Put/Call ratio
-
168%
-
Price per share
-
$41.21
-
Number of holders
-
164
-
Value change
-
+$79,358,837
-
Number of buys
-
114
-
Number of sells
-
43
Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share (DNTH) as of Q4 2025
As of 31 Dec 2025,
Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share (DNTH) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,004,390 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Octagon Capital Advisors LP, Fairmount Funds Management LLC, Avidity Partners Management LP, VANGUARD GROUP INC, BlackRock, Inc., TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., and STATE STREET CORP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.